Key Takeaways
- Q1 earnings from Lemonade scheduled for April 29, pre-market hours
- Analysts anticipate $254.03 million in revenue, representing a 68% annual increase
- Projected loss of $0.58 per share, marking a 32.6% improvement versus last year
- Morgan Stanley elevated LMND to Buy rating with $85 target, highlighting AV insurance opportunity
- Implied volatility suggests approximately 14.66% stock movement post-earnings
The year 2026 hasn’t been kind to Lemonade shareholders. Shares have slipped roughly 8% since January, pressured by inflation worries, softness in real estate markets, and uncertainty surrounding future expansion opportunities. However, this Wednesday’s first-quarter financial results could quickly shift investor sentiment.
Analysts are projecting Q1 revenue to reach $254.03 million, representing a substantial 68% surge compared to the prior-year period. This forecast is particularly notable given that it accelerates from the 53% revenue expansion Lemonade delivered during the fourth quarter of 2025.
On the bottom line, the consensus estimate points to a loss of $0.58 per share. Though the company remains unprofitable, this figure would represent meaningful progress — a 32.6% reduction in losses year over year. For a growth-stage company, trajectory often matters more than current profitability.
The options market is signaling heightened expectations around volatility. Current pricing implies a potential swing of approximately 14.66% in either direction once results are disclosed. Such a wide range underscores the uncertainty surrounding Wednesday’s announcement.
The company has demonstrated an ability to surpass Wall Street’s projections. In multiple recent reporting periods, Lemonade has exceeded analyst forecasts for both revenue and earnings per share, establishing a track record of positive surprises.
Entering this quarter, the company reported in-force premium of $1.24 billion as of Q4’s close, marking 31% year-over-year growth. This milestone extended a nine-quarter streak of accelerating growth — one of the most compelling metrics supporting the bullish thesis.
Customer acquisition also remains robust. Throughout 2025, Lemonade onboarded approximately 550,000 new policyholders — a 35% increase from the previous year. Importantly, this expansion spanned pet, auto, and homeowners insurance, demonstrating the platform’s multi-product appeal.
Autonomous Vehicle Partnership Takes Center Stage
A significant narrative heading into the earnings call involves Lemonade’s specialized insurance offering for Tesla Full Self-Driving customers. The insurer has committed to reducing per-mile premiums by approximately 50% for FSD-enabled vehicles, staking an early claim in the emerging autonomous vehicle insurance market.
Morgan Stanley’s Bob Huang recently shifted his stance on LMND from Hold to Buy, simultaneously lifting his price objective from $80 to $85. The upgrade emphasized Lemonade’s first-mover positioning in autonomous vehicle coverage as a potentially significant competitive moat.
Critical Metrics Under the Microscope
Beyond headline revenue and earnings figures, Wall Street observers will be scrutinizing updates regarding bad debt developments and interest expense trends — both factors that negatively impacted fourth-quarter performance. Additionally, concerns about rising interest rates stemming from geopolitical tensions, particularly the Iran situation, add another dimension to the analysis.
Industry peers in the property and casualty segment have already released their results. Stewart Information Services exceeded expectations by 4.7% and saw shares climb 3.9%. First American Financial topped estimates by 2.4%, driving a 3.5% stock advance. The broader P&C insurance sector has gained 6.7% over the trailing month.
Lemonade has actually outperformed this benchmark, rising 12.3% during the same timeframe, despite remaining in negative territory for the year.
Analyst sentiment currently stands at Hold — comprising two Buy ratings, four Holds, and two Sell recommendations. The consensus price target of $54.40 suggests potential downside from the current trading price of $65.95. Morgan Stanley’s $85 projection represents the most optimistic view on Wall Street.
Results will be released before market open on April 29.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
